Location History:
- Erie, CO (US) (2012)
- Boulder, CO (US) (2020)
Company Filing History:
Years Active: 2012-2020
Title: Brian C Baer: Innovator in Kinase Inhibition
Introduction
Brian C Baer is a notable inventor based in Erie, Colorado. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. With a total of 2 patents, Baer is recognized for his innovative approaches to treating various diseases.
Latest Patents
One of Baer's latest patents is focused on a compound known as ((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea, which serves as a TrkA kinase inhibitor. This compound is particularly useful in treating diseases such as pain, cancer, inflammation, neurodegenerative diseases, and several others. His work also includes pyrazole urea derivatives that are utilized as kinase inhibitors, which are beneficial in the treatment and prevention of various disorders mediated by kinases.
Career Highlights
Baer is currently associated with Array Biopharma Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions for complex medical challenges.
Collaborations
Throughout his career, Baer has collaborated with esteemed colleagues, including Mark C Munson and Shelley Allen. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Brian C Baer exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to kinase inhibition are paving the way for new treatments that address critical health issues.